Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

    Holmström, M. O., Gimsing, P., Abildgaard, N., Andersen, N. F., Helleberg, C., Clausen, N. A. T., Klausen, T. W., Frederiksen, M., Kristensen, D. L., Larsen, H., Pedersen, P. T., Andersen, K. T., Pedersen, R. S., Jensen, B. A., Gregersen, H. & Vangsted, Annette Juul, Apr 2015, In: American Journal of Hematology. 90, 4, p. E73-E74

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Published

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients

    Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Hematological Oncology. 39, 4, p. 521-528

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Interferon-alpha in the treatment of multiple myeloma

    Khoo, T. L., Joshua, D., Gibson, J. & Vangsted, Annette Juul, 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 437-446 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

    Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, Annette Juul, Feb 2019, In: Leukemia. 33, 2, p. 546-549 4 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  5. Published

    Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

    Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Hansson, M., Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, Annette Juul, Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U. & Nahi, H., 2018, In: Cancer Medicine. 7, 6, p. 2256-2268 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Bisfosfonatassocieret osteonekrose i kaeberne hos patienter med myelomatose

    Lund, T., Gregersen, H., Vangsted, Annette Juul, Marker, P. & Abildgaard, N., 2009, In: Ugeskrift for læger. 171, 1-2, p. 50-2 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    MacAuda, A., Clay-Gilmour, A., Hielscher, T., Hildebrandt, M. A. T., Kruszewski, M., Orlowski, R. Z., Kumar, S. K., Ziv, E., Orciuolo, E., Brown, E. E., Försti, A., Waller, R. G., MacHiela, M. J., Chanock, S. J., Camp, N. J., Rymko, M., Raźny, M., Cozen, W., Várkonyi, J., Piredda, C. & 36 others, Pelosini, M., Belachew, A. A., Subocz, E., Hemminki, K., Rybicka-Ramos, M., Giles, G. G., Milne, R. L., Hofmann, J. N., Zaucha, J. M. I., Vangsted, Annette Juul, Goldschmidt, H., Rajkumar, S. V., Tomczak, W., Sainz, J., Butrym, A., Watek, M., Iskierka-Jazdzewska, E., Buda, G., Robinson, D. P., Jurczyszyn, A., Dudzinski, M., Martinez-Lopez, J., Sinnwell, J. P., Slager, S. L., Jamroziak, K., Reis, R. M. V., Weinhold, N., Bhatti, P., Carvajal-Carmona, L. G., Zawirska, D., Norman, A. D., Mazur, G., Berndt, S. I., Campa, D., Vachon, C. M. & Canzian, F., 2022, In: Cancer Epidemiology Biomarkers and Prevention. 31, 9, p. 1863-1866

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Identification of miRSNPs associated with the risk of multiple myeloma

    Macauda, A., Calvetti, D., Maccari, G., Hemminki, K., Försti, A., Goldschmidt, H., Weinhold, N., Houlston, R., Andersen, V., Vogel, U., Buda, G., Varkonyi, J., Sureda, A., Martinez Lopez, J., Watek, M., Butrym, A., Sarasquete, M. E., Dudziński, M., Jurczyszyn, A., Druzd-Sitek, A. & 36 others, Kruszewski, M., Subocz, E., Petrini, M., Iskierka-Jażdżewska, E., Raźny, M., Szombath, G., Marques, H., Zawirska, D., Chraniuk, D., Halka, J., Hove Jacobsen, S. E., Mazur, G., García Sanz, R., Dumontet, C., Moreno, V., Stępień, A., Beider, K., Pelosini, M., Manuel Reis, R., Krawczyk-Kulis, M., Rymko, M., Avet-Loiseau, H., Lesueur, F., Grząśko, N., Ostrovsky, O., Jamroziak, K., Vangsted, Annette Juul, Jerez, A., Tomczak, W., Zaucha, J. M., Kadar, K., Sainz, J., Nagler, A., Landi, S., Gemignani, F. & Canzian, F., 1 Feb 2017, In: International Journal of Cancer. 140, 3, p. 526-534 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

    Macauda, A., Castelli, E., Buda, G., Pelosini, M., Butrym, A., Watek, M., Kruszewski, M., Vangsted, A. J., Rymko, M., Jamroziak, K., Abildgaard, N., Haastrup, E. K., Mazur, G., Ríos, R., Jurczyszyn, A., Zawirska, D., Dudziński, M., Raźny, M., Dutka, M., Tomczak, W. & 11 others, Suska, A., Druzd-Sitek, A., Marques, H., Petrini, M., Markiewicz, M., Martinez-Lopez, J., Ebbesen, L. H., Iskierka-Jażdżewska, E., Sainz, J., Canzian, F. & Campa, D., 2018, In: British Journal of Haematology. 183, 3, p. 375-384 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

    Martino, A., Campa, D., Canzian, F., Jamroziak, K., Szemraj-Rogucka, Z., Reis, R. M., Marques, H., Sainz, J., Jurado, M., Ríos, R., Buda, G., Orciuolo, E., Petrini, M., García-Sanz, R., Lesueur, F., Moreno, V., Szemraj, J., Tjønneland, A., Overvad, K., Vangsted, A. J. & 11 others, Vogel, U. B., Mikala, G., Kádár, K., Szombath, G., Varkonyi, J., Dumontet, C., Gemignani, F., Rossi, A. M., Landi, S., Houlston, R. S. & Hemminki, K., 1 Sep 2012, In: British Journal of Haematology. 158, 6, p. 805-809 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 9762536